Literature DB >> 8318906

Cancer cell societies and tumor progression.

G H Heppner1.   

Abstract

It is now well accepted that cancers are heterogeneous and contain multiple subpopulations of cancer cells that differ in important behavioral properties, such as growth rate, ability to metastasize and sensitivity to treatment. This review describes results using a mouse mammary tumor system to model the effect of heterogeneity on tumor growth and response to chemotherapy. Tumor subpopulations that differ in growth and therapy parameters are mixed together to simulate tumor heterogeneity. The mixtures are studied in a variety of protocols designed to detect interactions between the subpopulations and to determine the mechanisms of these interactions. The central conclusion of this work is that tumor subpopulations do not behave independently of each other but rather form a society of cells in which they influence each other's growth and treatment response. The mechanisms by which they do so depend on the unique characteristics of the interacting subpopulations, on the behavior being affected and on the circumstances of their interaction. These observations suggest that the maintenance of tumor heterogeneity is a consequence of the cancer cell society and that cancer behavior and progression depend on interactions among all the members of that society, not just on its most deviant variants.

Entities:  

Mesh:

Year:  1993        PMID: 8318906     DOI: 10.1002/stem.5530110306

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  15 in total

1.  First principles of Hamiltonian medicine.

Authors:  Bernard Crespi; Kevin Foster; Francisco Úbeda
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-03-31       Impact factor: 6.237

Review 2.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

3.  Selection of more aggressive variants of the gI101A human breast cancer cell line: a model for analyzing the metastatic phenotype of breast cancer.

Authors:  Dina Chelouche Lev; Galina Kiriakova; Janet E Price
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 4.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

5.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

Review 6.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

7.  Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems.

Authors:  Sapan J Patel; Su Dao; Costel C Darie; Bayard D Clarkson
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

8.  Altered TGF-α/β signaling drives cooperation between breast cancer cell populations.

Authors:  Omar E Franco; Darren R Tyson; Katherine C Konvinse; Akshata R Udyavar; Lourdes Estrada; Vito Quaranta; Susan E Crawford; Simon W Hayward
Journal:  FASEB J       Date:  2016-07-06       Impact factor: 5.191

Review 9.  Societal interactions in ovarian cancer metastasis: a quorum-sensing hypothesis.

Authors:  Jonathan Hickson; S Diane Yamada; Jonathan Berger; John Alverdy; James O'Keefe; Bonnie Bassler; Carrie Rinker-Schaeffer
Journal:  Clin Exp Metastasis       Date:  2008-05-31       Impact factor: 5.150

10.  Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers.

Authors:  Allison S Cleary; Travis L Leonard; Shelley A Gestl; Edward J Gunther
Journal:  Nature       Date:  2014-04-03       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.